About Pharma Industry

BNET Pharma provides daily industry trends and news coverage with insights for managers and executives about major manufacturers of pharmaceuticals and medicine. In addition to detailed drug company profiles, we bring you industry analysis on new partnerships, drug patents and products, cost management, investments, pharmaceutical related lawsuits, and a host of other important business issues.

Merck Created Hit List to "Destroy," "Neutralize" or "Discredit" Dissenting Doctors

By Jim Edwards | May 6, 2009

Merck made a “hit list” of doctors who criticized Vioxx, according to testimony in a Vioxx class action case in Australia. The list, emailed between Merck employees, contained doctors’ names with the labels “neutralise,” “neutralised” or “discredit” next to them.

According to The Australian, Merck emails from 1999 showed company execs complaining about doctors who disliked using Vioxx. One email said:

We may need to seek them out and destroy them where they live …

The plaintiffs’ lawyer gave this assessment:

It gives you the dark side of the use of key opinion leaders and thought leaders … if (they) say things you don’t like to hear, you have to neutralise them … It does suggest a certain culture within the organisation about how to deal with your opponents and those who disagree with you.

The Australian:

The court was told that James Fries, professor of medicine at Stanford University, wrote to the then Merck head Ray Gilmartin in October 2000 to complain about the treatment of some of his researchers who had criticised the drug.

“Even worse were allegations of Merck damage control by intimidation,” he wrote,  … “This has happened to at least eight (clinical) investigators … I suppose I was mildly threatened myself but I never have spoken or written on these issues.”

The allegations come on the heels of revelations that Merck created a fake medical journal — the Australasian Journal of Bone and Joint Medicine — in which to publish studies about Vioxx; had pop songs commissioned about Vioxx to inspire its staff, and paid ghostwriters to draft articles about the drug.

Tags: Jim Edwards

Jim Edwards, a former managing editor of Adweek, has covered drug marketing at Brandweek for four years, and is a former Knight-Bagehot fellow at Columbia University's business and journalism schools. Follow him on Twitter or send him an email.

BNET User Analysis

Web Buzz:
  • Merck - Vioxx: silencing critics - "We may need to seek them out and destroy them where they live,"

    PharmaGossip - 315 days 9 hours 36 minutes ago

    AN international drug company made a hit list of doctors who had to be "neutralised" or discredited because they criticised the anti-arthritis drug the pharmaceutical giant produced. Staff at US company Merck &Co emailed each other about the list of doctors - mainly researchers and academics - who had been negative about the drug Vioxx or Merck...

  • Docs Say Merck Placed Their Names on Ghostwritten Vioxx Articles

    BNET Pharma - 273 days 8 hours 37 minutes ago

    Not only did Merck produce a series of fake medical journals to promote Vioxx in Australia, but the articles were ghostwritten by doctors who deny they worked on them, according to Heartwire. Dr. Marvin Konstam said he didn’t know too much about a 2001 journal article on Vioxx, despite the fact that he was listed as the article’s lead...

  • Why Merck Will Win Its Vioxx Supreme Court Case

    BNET Pharma - 257 days 6 hours 54 minutes ago

    Merck should expect to win when the U.S. Supreme Court takes the shareholder class action case filed against it over the Vioxx withdrawal. Investors allege that Merck committed securities fraud because it hid knowledge that Vioxx was dangerous until September 2004, when it was withdrawn from the market because it caused too many cardiovascular...

  • Merck - Vioxx: "scientifically unsound" marketing

    PharmaGossip - 278 days 17 hours 50 minutes ago

    PHARMACEUTICAL giant Merck & Co put its patients at risk of heart attack by making "scientifically unsound" claims and corrupting studies about its blockbuster drug Vioxx, a leading arthritis expert told the Federal Court. Royal Adelaide Hospital director of rheumatology Les Cleland, who was identified by Merck marketing staff as a Vioxx...

  • New Merck Allegations: A Fake Journal; Ghostwritten Studies; Vioxx Pop Songs; PR Execs Harass Reporters

    BNET Pharma - 292 days 3 hours 47 minutes ago

    Federal prosecutors in the U.S. will be reading with amusement the Australian press’s coverage of a class action trial down under for patients who took Merck’s now-withdrawn painkiller Vioxx. Details emerging in Oz make some of the antics that Merck’s American counterparts got up to look tame by comparison. For example, in Australia, Merck...

Links from the Web Buzz:
 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
Click Here
advertisement
Click Here